Happy 2022 and everything goes well

News 2021.12.316826

Related News

Innovative Application of Lipoic Acid-Boronophenylalanine Derivatives in BNCT: Neuboron Facilitates New Research Breakthroughs

2025.02.19
China's First! Neuboron's Domestic Boron Drug Approved for IND Clinical Trials

2024.01.09
Neuboron Medical Group's cutting-edge Boron Neutron Capture Therapy（BNCT） product were presented at the ICNCT-19 conference

2021.10.01
Great News! Neuboron Wins First Prize of 2023 China Radiation Protection Society Science and Technology Award

2024.09.12